Thyroid function profile in children with epilepsy receiving sodium valproate monotherapy: a cross-sectional study from North India
DOI:
https://doi.org/10.18203/2349-3291.ijcp20262952Keywords:
Anticonvulsants, Children, Epilepsy, Hypothyroidism, Sodium valproate, Thyroid function testsAbstract
Background: To evaluate the thyroid function profile in children with epilepsy receiving sodium valproate monotherapy for at least six months and to determine the prevalence and correlates of thyroid dysfunction.
Methods: A hospital-based cross-sectional observational study was conducted at a tertiary care centre in Jaipur, Rajasthan, over 12 months (January–December 2024). Sixty-five children aged 1–17 years on sodium valproate monotherapy for a minimum of six months were enrolled by consecutive sampling. Thyroid function tests (free triiodothyronine (fT3), free thyroxine (fT4) and thyroid-stimulating hormone (TSH)) were measured at enrollment and compared with baseline values obtained prior to therapy initiation. Thyroid status was classified as euthyroid, subclinical hypothyroidism (TSH >5 µIU/ml with normal fT3 and fT4) or overt hypothyroidism. Associations with age, sex, valproate dose and duration of therapy were analyzed using the chi-square test and paired t-test.
Results: After ≥6 months of valproate therapy, 44.62% of children developed subclinical hypothyroidism, 20.00% developed overt hypothyroidism and only 35.38% remained euthyroid. Paired t-test revealed significant increases in mean TSH (2.25±0.37 vs 5.49±2.68 µIU/ml; p<0.001), a decrease in mean fT4 (1.42±0.05 vs 1.20±0.18 ng/dl; p<0.001) and a mild increase in mean fT3 (3.61±0.16 vs 3.72±0.16 pg/ml; p<0.001). Thyroid dysfunction was significantly associated with older age (p<0.001), higher valproate dose (p=0.015) and longer duration of therapy (p=0.006), but not with sex (p=0.833).
Conclusions: Sodium valproate monotherapy is associated with significant thyroid dysfunction in a substantial proportion of children, even within the first six months of therapy. Older age, higher doses and longer treatment duration are important risk factors. Routine monitoring of thyroid function is recommended for all children on long-term valproate therapy.
References
Fisher RS, Acevedo C, Arzimanoglou A. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-82.
Amudhan S, Gururaj G, Satishchandra P. Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol. 2015;18(3):263-77.
Jain P, Garg D, Sharma S. Profile of pediatric epilepsy: An experience from a tertiary care center in Rajasthan. J Pediatr Neurosci. 2017;12(1):28-32.
Glauser TA, Cnaan A, Shinnar S. Ethosuximide, valproic acid and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010;362(9):790-9.
Koul R. Management of epilepsy in children. Indian J Pediatr. 2012;79(2):187-94.
Verrotti A, D'Egidio C, Mohn A. Endocrine and metabolic effects of antiepileptic drugs: A review. Curr Drug Saf. 2011;6(4):270-7.
Verrotti A, D'Egidio C, Agostinelli S. Valproate-induced endocrine disorders. CNS Drugs. 2009;23(10):763-76.
Ogilvy-Stuart AL, Midgley PC, Gregory JW. The effect of sodium valproate on thyroid function. Arch Dis Child. 1991;66(7):804-6.
Chen HF, Su LT, Chen PC. Risk of thyroid disorders in children with epilepsy receiving valproate: A population-based cohort study. Thyroid. 2013;23(2):178-84.
Wirrell EC. Epilepsy-related comorbidities in children: Impact on quality of life. Epilepsia. 2016;57(9):1406-12.
Güngör O, Kendirci M, Sahin M. Subclinical hypothyroidism in children with epilepsy on valproate. Epilepsy Res. 2020;159:106247.
Malwade SD, Bhosle MV, Nimbalkar M. Thyroid dysfunction in children with epilepsy on valproate monotherapy. J Pediatr Neurosci. 2018;13(2):122-6.
Ilić V, Đorđević V, Nikolić G. Valproic acid monotherapy and subclinical thyroid dysfunction duration-dependent effects in children with epilepsy. Epilepsy Res. 2016;121:1-5.
Alhyan R, Shah R, Aggarwal N. Thyroid profile in epileptic children on sodium valproate monotherapy: A six-month prospective Indian study. Indian J Pediatr. 2023;90(4):331-6.
Radhakrishnan A, Menon R, Bindu PN. Thyroid dysfunction in children with epilepsy on valproate monotherapy: Need for periodic monitoring. Indian Pediatr. 2015;52(7):579-82.
Kim SH, Chung HR, Kim SH, Kim H, Lim BC, Chae JH, et al. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy. Neuropediatrics. 2012;43(3):135-9.
Panda PK, Sharawat IK, Dawman L. Thyroid function test abnormalities in children on valproate monotherapy: A prospective observational study. J Pediatr Neurosci. 2018;13(2):122-6.
Tomoum HY, Badr El-Din MK, Ali YF. Endocrinal and metabolic profiles in children with idiopathic epilepsy: Impact of anticonvulsants. J Child Neurol. 2010;25(12):1420-6.
Carolina IY, Anidar A, Andid R. Treatment duration and dosage of valproic acid and subclinical hypothyroidism incidence in pediatric epilepsy patients. Paediatr Indones. 2024;64(1):45-52.
Rafik A, Ismail HM, Eltellawy N. Thyroid and metabolic effects of antiseizure medications in Egyptian children with epilepsy. Epilepsy Behav. 2024;153:109679.
Cansu A, Serdaroğlu A, Camurdan O. Thyroid functions, thyroid antibodies and thyroid volumes in children with epilepsy on oxcarbazepine and valproate. Epilepsia. 2006;47(11):1855-9.
Attilakos A, Katsarou E, Prassouli A. Methylenetetrahydrofolate reductase gene polymorphism and homocysteine levels in children treated with sodium valproate. J Child Neurol. 2009;24(2):190-4.
Verrotti A, Basciani F, Morresi S. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatr Neurol. 2001;25(1):43-6.
Verrotti A, Coppola G, Parisi P. Thyroid function and subclinical hypothyroidism in children receiving valproic acid. Epilepsy Res. 2009;86(2-3):232-5.
Han Y, Huang Z, Li X. Effects of oral anti-seizure drugs on thyroid hormones in epilepsy: A systematic review and network meta-analysis. Epilepsia. 2022;63(6):1386-97.
Dhodi DK, Bhagat SB, Rathi MA. Thyroid function tests in epileptic children on valproate monotherapy. Int J Contemp Pediatr. 2020;7(6):1275-8.
Downloads
Published
How to Cite
Issue
Section
